{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:51:09Z","timestamp":1790805069890,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2495,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      <jats:bold>The diagnostic criteria for autoimmune hepatitis (AIH) have been codified by an international panel, and a revision of the original scoring system based on 12 clinical components has been promulgated. A simplified scoring system has been proposed recently that is based on four clinical components. The goals of this study were to compare the performance parameters of the revised original and the simplified scoring systems and to determine the prowess of each as a diagnostic instrument. Diagnostic scores were determined using each scoring system in 435 patients with diverse chronic liver diseases, including 153 individuals with AIH by codified clinical criteria. The sensitivity, specificity, and predictability of each scoring system for the pretreatment diagnosis of AIH were determined. The revised original scoring system had greater sensitivity for the diagnosis than the simplified scoring system (100% versus 95%), and seven patients diagnosed as AIH using the revised original system were nondiagnostic by the simplified system (5%). The revised original scoring system also ascribed a diagnosis of AIH to 20 of 21 patients with cryptogenic chronic hepatitis, whereas only five patients were similarly classified by the simplified system (95% versus 24%). The simplified system had greater specificity (90% versus 73%) and predictability (92% versus 82%) for AIH than the revised original system, and it more commonly excluded the diagnosis in other diseases with concurrent immune features (83% versus 64%).<\/jats:bold>\n                      <jats:bold>Conclusion:<\/jats:bold>\n                      <jats:bold>The revised original scoring system performs better in patients with few or atypical features of AIH, and the simplified system is better at excluding the diagnosis in diseases with concurrent immune manifestations. Each system has attributes that can be exploited. (Hepatology 2008.)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.22513","type":"journal-article","created":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T09:06:23Z","timestamp":1215594383000},"page":"1540-1548","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":187,"title":["Performance parameters of the diagnostic scoring systems for autoimmune hepatitis"],"prefix":"10.1097","volume":"48","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20241201","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report. International Autoimmune Hepatitis Group.","volume":"18","author":"Johnson","year":"1993","journal-title":"HEPATOLOGY"},{"key":"R2-23-20241201","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis.","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R3-23-20241201","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02093820","article-title":"Validation of a scoring system for the diagnosis of autoimmune hepatitis.","volume":"41","author":"Czaja","year":"1996","journal-title":"Dig Dis Sci"},{"key":"R4-23-20241201","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis.","volume":"23","author":"Boberg","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R5-23-20241201","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified diagnostic criteria for autoimmune hepatitis.","volume":"48","author":"Hennes","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R6-23-20241201","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis.","volume":"36","author":"Czaja","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R7-23-20241201","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging.","volume":"19","author":"Desmet","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R8-23-20241201","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B.","volume":"45","author":"Lok","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R9-23-20241201","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease.","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology"},{"key":"R10-23-20241201","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD SingleTopic Conference.","volume":"37","author":"NeuschwanderTetri","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R11-23-20241201","first-page":"178","article-title":"Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria.","volume":"30","author":"Taal","year":"1983","journal-title":"Hepatogastroenterology"},{"key":"R12-23-20241201","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(80)90131-6","article-title":"Clinicopathologic features of the syndrome of primary sclerosing cholangitis.","volume":"79","author":"Wiesner","year":"1980","journal-title":"Gastroenterology"},{"key":"R13-23-20241201","doi-asserted-by":"crossref","first-page":"510","DOI":"10.7326\/0003-4819-119-6-199309150-00011","article-title":"Chronic active hepatitis: the challenge for a new nomenclature.","volume":"119","author":"Czaja","year":"1993","journal-title":"Ann Intern Med"},{"key":"R14-23-20241201","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","article-title":"The variant forms of autoimmune hepatitis.","volume":"125","author":"Czaja","year":"1996","journal-title":"Ann Intern Med"},{"key":"R15-23-20241201","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/0016-5085(93)90656-W","article-title":"The nature and prognosis of severe cryptogenic chronic active hepatitis.","volume":"104","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"R16-23-20241201","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-006-9665-4","article-title":"Corticosteroidresponsive cryptogenic chronic hepatitis: evidence of seronegative autoimmune hepatitis.","volume":"52","author":"Gassert","year":"2007","journal-title":"Dig Dis Sci"},{"key":"R17-23-20241201","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1053\/j.gastro.2006.08.020","article-title":"Utility of a new model to diagnose an alcohol basis for steatohepatitis.","volume":"131","author":"Dunn","year":"2006","journal-title":"Gastroenterology"},{"key":"R18-23-20241201","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","article-title":"Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis.","volume":"24","author":"Czaja","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R19-23-20241201","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1023\/A:1018809431189","article-title":"Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis.","volume":"42","author":"Czaja","year":"1997","journal-title":"Dig Dis Sci"},{"key":"R20-23-20241201","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","article-title":"Frequency and significance of antibodies to liverkidney microsome type 1 in adults with chronic active hepatitis.","volume":"103","author":"Czaja","year":"1992","journal-title":"Gastroenterology"},{"key":"R21-23-20241201","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/0016-5085(93)90160-E","article-title":"Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"R23-23-20241201","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","article-title":"Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis.","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"R24-23-20241201","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.cgh.2007.05.031","article-title":"Optimizing diagnosis from the medical liver biopsy.","volume":"5","author":"Czaja","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-23-20241201","first-page":"1087","article-title":"Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy.","volume":"20","author":"Soloway","year":"1975","journal-title":"Am J Dig Dis"},{"key":"R26-23-20241201","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis.","volume":"25","author":"Czaja","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R27-23-20241201","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00007890-199011000-00024","article-title":"Comparison of RFLPDR beta and serological HLADR typing in 1500 individuals.","volume":"50","author":"Mytilineos","year":"1990","journal-title":"Transplantation"},{"key":"R29-23-20241201","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease.","volume":"28","author":"Czaja","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R30-23-20241201","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0168-8278(96)80186-3","article-title":"Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis.","volume":"24","author":"Czaja","year":"1996","journal-title":"J Hepatol"},{"key":"R31-23-20241201","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1023\/B:DDAS.0000004522.36120.08","article-title":"Nonorganspecific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates.","volume":"48","author":"Loria","year":"2003","journal-title":"Dig Dis Sci"},{"key":"R32-23-20241201","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease.","volume":"99","author":"Adams","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R33-23-20241201","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2005.11.037","article-title":"Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries.","volume":"44","author":"Czaja","year":"2006","journal-title":"J Hepatol"},{"key":"R34-23-20241201","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1572-0241.2002.05703.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system.","volume":"97","author":"Talwalkar","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R35-23-20241201","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.20539","article-title":"Treatment challenges and investigational opportunities in autoimmune hepatitis.","volume":"41","author":"Czaja","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R36-23-20241201","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.","volume":"42","author":"Feld","year":"2005","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22513","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200811000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:35:53Z","timestamp":1733042153000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200811000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22513","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}